CFX — Stock Film
STOCK FILMSCENE 1/11CFX · $39.06
Stock Expert AI presents
CFX
Colfax Corporation
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Colfax Corporation. A quick introduction.

On the stock market since 2008, it operates in the world of heavy industry. It has 16,200 employees. Now — the numbers.

on the stock market since 2008
16K employees
$2.1B market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.5.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

WHERE DOES THE MONEY COME FROM?
63%Fabrication Technology
Fabrication Technology 63%Medical Technology 37%
63% of all revenue comes from a single line: Fabrication Technology.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

THE SALES TREND
Sales have been shrinking.

An average decline of 9% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$3.3B
2019
$3.1B
2020
$3.9B
2021
$2.1B
2024
$2.2B
2025
In the vault right now:
$0
DEBT: $93M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Growth has stalled4/10
Costs eat into the margin4/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 26% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
Sales are holding up

The company sells $2.2B a year; the problem isn’t sales — it’s costs running above that number.

2
THE BRIGHT SIDE · 2/3
Delivers on expectations

It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.

3
THE BRIGHT SIDE · 3/3
Analysts’ target sits above today’s price

The average analyst price target is $51.0031% above today’s price.

1
THE RISKS · 1/3
The losses continue

A loss of $1.2B against $2.2B in annual sales.

2
THE RISKS · 2/3
A wildly swinging price

This stock swings about 2.1 times as much as the market average. Big rallies — and big drops — can both happen fast.

3
THE RISKS · 3/3
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, CFX sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: CFX has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film